Astria Therapeutics, Inc.
NASDAQ:ATXS
9.15 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -72.891 | -51.834 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 | -36.06 | -32.63 | -21.884 | -18.118 | -0.016 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0.026 | 0.119 | 0.304 | 0.395 | 0.202 | 0.248 | 0.32 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0.023 | -0.303 | -0.004 | 0.096 | 0 | 0 | -0.343 | 0 |
| Stock Based Compensation
| 6.314 | 4.554 | 3.362 | 1.39 | 1.512 | 1.771 | 2.007 | 2.16 | 1.658 | 0.897 | 0.343 | 0 |
| Change In Working Capital
| -2.413 | 2.647 | -3.305 | 3.367 | -1.87 | 0.762 | -1.934 | 0.274 | 0.684 | 0.253 | 1.089 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.725 | -0.766 | -1.965 | 0.347 | -0.211 | 0.662 | -0.632 | 0.077 | 0.196 | 0.481 | -0.129 | 0 |
| Other Working Capital
| -3.138 | 3.413 | -1.34 | 3.02 | -1.659 | 0.1 | -1.302 | 0.197 | 0.488 | -0.228 | 1.218 | 0 |
| Other Non Cash Items
| 0.545 | 1.1 | 164.704 | 0.058 | 0.033 | 0.056 | 0.155 | 0.277 | 0.293 | 0.074 | 0.343 | -0 |
| Operating Cash Flow
| -68.445 | -43.533 | -30.151 | -32.485 | -26.569 | -23.465 | -26.836 | -32.858 | -29.793 | -20.412 | -16.366 | -0.016 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.025 | -0.091 | -0.021 | -0.033 | -0.012 | 0.018 | -0.057 | -0.459 | -0.421 | -0.228 | -0.043 | -0 |
| Acquisitions Net
| 0 | 0.167 | 6.466 | -0.006 | 0.004 | -0.018 | 45.539 | 0.052 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1,924.423 | -396.064 | -78 | -62.777 | -155.197 | -70.364 | -45.539 | -45.539 | 0 | -4.976 | 0 | 0 |
| Sales Maturities Of Investments
| 2,059.5 | 229.026 | 59 | 69.11 | 151.127 | 48.09 | 14.91 | 30.456 | 0 | 4.976 | 0 | 0 |
| Other Investing Activites
| 0 | -0.167 | -0.013 | 0.006 | -0.004 | 0.369 | 0.03 | 0.052 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 135.052 | -167.129 | -12.555 | 6.3 | -4.082 | -21.905 | 14.883 | -15.49 | -0.421 | -0.228 | -0.043 | -0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | -2.848 | -3.333 | -3.333 | 4.167 | 5 | 0 | 0 |
| Common Stock Issued
| 87.978 | 144.637 | 104.261 | 40.829 | 25.566 | 47.139 | 8.036 | 11.994 | 61.744 | 0 | 0 | 8.746 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.42 | 0.084 | 0.023 | 0.031 | 0.054 | 0.004 | 0.023 | 0.503 | 12.415 | -0.166 | 41.449 | 0 |
| Financing Cash Flow
| 88.398 | 144.721 | 104.284 | 40.86 | 25.62 | 44.295 | 4.726 | 9.164 | 78.326 | 4.834 | 41.449 | 0.009 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 155.005 | -65.941 | 61.578 | 14.675 | -5.031 | -1.075 | -7.227 | -39.184 | 48.112 | -15.806 | 25.04 | -0.007 |
| Cash At End Of Period
| 175.693 | 20.688 | 86.629 | 25.051 | 10.376 | 15.407 | 16.369 | 23.596 | 62.78 | 14.668 | 30.474 | 0.005 |